Global COPD Drugs Market Projected to Reach USD 33.28 Billion by 2034
The Chronic Obstructive Pulmonary Disease Drugs Market, reporting that the global valuation stood at USD 21.27 billion in 2025 and is poised to scale up to USD 33.28 billion over the forecast period. As the third leading cause of mortality worldwide, COPD presents an escalating clinical and economic burden, accelerating the corporate imperative for precision respiratory care, targeted...
